The firm also lowered 2015 earnings estimates to $3.70 from $4.05 per share, with 2016 earnings estimates lowered to $3.95 from $4.55 and 2017 earnings estimates to $4.55 from $5.45 per share, respectively.
However, Jefferies believes that DuPont will make meaningful progress this year based on crop protection, tangible cost cuts, and another round of structural improvement of Ethylene co-polymers for packaging application, aramids, and electronic chemicals.
"We expect DuPont shares to be range-bound near-term, and then to be lifted into 2016 earnings on the combination of ongoing capital returns to shareholders and confirmation organic growth is improving across its portfolio," Jefferies analysts said.
Wilmington, Del.-based DuPont is a chemical company with multiple segments including agriculture, electronics and communications, industrial biosciences, nutrition and health, performance chemicals, performance coatings, performance materials, safety and protection, and pharmaceuticals.
Shares of DuPont were up 0.19% to $69.97 in afternoon trading Monday.
Separately, TheStreet Ratings team rates DU PONT (E I) DE NEMOURS as a Buy with a ratings score of A-. TheStreet Ratings Team has this to say about their recommendation:
"We rate DU PONT (E I) DE NEMOURS (DD) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations, notable return on equity and expanding profit margins. We feel its strengths outweigh the fact that the company has had sub par growth in net income."